FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Helen Pettinati

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Activities & Behaviors

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Toni-Kim Clarke; Richard C Crist; Charles Dackis; Thomas N Ferraro; Kyle M Kampman; Falk W Lohoff; Charles P O'Brien; David W Oslin; Helen M Pettinati; Wade H Berrettini
Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.
R C Crist; Charles Dackis; G A Doyle; T N Ferraro; H Hakonarson; Kyle M Kampman; Falk W Lohoff; Charles P O'Brien; David W Oslin; Helen M Pettinati; M Vaswani; C Yuan; A Zeng; L M Ambrose-Lanci; T K Clarke; W H Berrettini
Case-control association analysis of polymorphisms in the delta-opioid receptor, OPRD1, with cocaine and opioid addicted populations.
Charles Dackis; Kyle M Kampman; Kevin G Lynch; Helen M Pettinati; Jennifer G Plebani; Thorne Sparkman; Charles P O'Brien
A double-blind, placebo-controlled trial of modafinil for cocaine dependence.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Helen Pettinati (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Toni-Kim Clarke; Richard C Crist; Charles Dackis; Thomas N Ferraro; Kyle M Kampman; Falk W Lohoff; Charles P O'Brien; David W Oslin; Helen M Pettinati; Wade H Berrettini
Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.
Neuroscience letters 2013;542():71-5.
2013: R C Crist; Charles Dackis; G A Doyle; T N Ferraro; H Hakonarson; Kyle M Kampman; Falk W Lohoff; Charles P O'Brien; David W Oslin; Helen M Pettinati; M Vaswani; C Yuan; A Zeng; L M Ambrose-Lanci; T K Clarke; W H Berrettini
Case-control association analysis of polymorphisms in the delta-opioid receptor, OPRD1, with cocaine and opioid addicted populations.
Drug and alcohol dependence 2013;127(1-3):122-8.
2012: Charles Dackis; Kyle M Kampman; Kevin G Lynch; Helen M Pettinati; Jennifer G Plebani; Thorne Sparkman; Charles P O'Brien
A double-blind, placebo-controlled trial of modafinil for cocaine dependence.
Journal of substance abuse treatment 2012;43(3):303-12.
2012: Jennifer G Plebani; Qin Yu; Kevin G Lynch; Charles P O'Brien; Helen M Pettinati; Kyle M Kampman
Results of an initial clinical trial of varenicline for the treatment of cocaine dependence.
Drug and alcohol dependence 2012;121(1-2):163-6.
2011: Charles P O'Brien; David Gastfriend; Robert F Forman; Edward Schweizer; Helen M Pettinati
Long-term opioid blockade and hedonic response: preliminary data from two open-label extension studies with extended-release naltrexone.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2011;20(2):106-12.
2011: Kyle M Kampman; Charles Dackis; Helen M Pettinati; Kevin G Lynch; Thorne Sparkman; Charles P O'Brien
A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence.
Addictive behaviors 2011;36(3):217-21.
2010: Shelly F Greenfield; Helen M Pettinati; Stephanie O'Malley; Patrick K Randall; Carrie L Randall
Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.
Alcoholism, clinical and experimental research 2010;34(10):1803-12.
2010: Falk W Lohoff; Paul J Bloch; Rachel Hodge; Aleksandra H Nall; Thomas N Ferraro; Kyle M Kampman; Charles Dackis; Charles P O'Brien; Helen M Pettinati; David W Oslin
Association analysis between polymorphisms in the dopamine D2 receptor (DRD2) and dopamine transporter (DAT1) genes with cocaine dependence.
Neuroscience letters 2010;473(2):87-91.
2010: Jennifer G Plebani; Carlos F Tirado; Helen M Pettinati; Kyle M Kampman; Joseph Robert Volpicelli; David W Oslin
Combined effects of alcohol and hepatitis C: a secondary analysis of alcohol use biomarkers and high-risk behaviors from two medication trials for alcohol dependence.
Addictive behaviors 2010;35(2):123-8.
2009: Paul J Bloch; Aleksandra H Nall; Andrew E Weller; Thomas N Ferraro; Wade H Berrettini; Kyle M Kampman; Helen M Pettinati; Charles Dackis; Charles P O'Brien; David W Oslin; Falk W Lohoff
Association analysis between polymorphisms in the dopamine D3 receptor (DRD3) gene and cocaine dependence.
Psychiatric genetics 2009;19(5):275-6.
2009: Kyle M Kampman; Helen M Pettinati; Kevin G Lynch; Hu Xie; Charles Dackis; David W Oslin; Thorne Sparkman; Tiffany Sharkoski; Charles P O'Brien
Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence.
Addictive behaviors 2009;34(6-7):581-6.
2009: Falk W Lohoff; Paul J Bloch; Thomas N Ferraro; Wade H Berrettini; Helen M Pettinati; Charles Dackis; Charles P O'Brien; Kyle M Kampman; David W Oslin
Association analysis between polymorphisms in the conserved dopamine neurotrophic factor (CDNF) gene and cocaine dependence.
Neuroscience letters 2009;453(3):199-203.
2009: Gabor Oroszi; Raymond F Anton; Stephanie O'Malley; Robert Swift; Helen M Pettinati; David J Couper; Qiaoping Yuan; David Goldman
OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach.
Alcoholism, clinical and experimental research 2009;33(3):383-93.
2009: Helen M Pettinati; David Gastfriend; Qunming Dong; Henry R Kranzler; Stephanie S O'Malley
Effect of extended-release naltrexone (XR-NTX) on quality of life in alcohol-dependent patients.
Alcoholism, clinical and experimental research 2009;33(2):350-6.
2009: ahmadi ahmad; Kyle M Kampman; David M Oslin; Helen M Pettinati; Charles Dackis; Thorne Sparkman
Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2009;18(1):81-6.
2008: Falk W Lohoff; Andrew E Weller; Paul J Bloch; Aleksandra H Nall; Thomas N Ferraro; Kyle M Kampman; Helen M Pettinati; David W Oslin; Charles Dackis; Charles P O'Brien; Wade H Berrettini
Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(13):3078-84.
2008: Jesse Suh; Helen M Pettinati; Kyle M Kampman; Charles P O'Brien
Gender differences in predictors of treatment attrition with high dose naltrexone in cocaine and alcohol dependence.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2008;17(6):463-8.
2008: Denise B Ernst; Helen M Pettinati; Roger D Weiss; Dennis Donovan; Richard Longabaugh
An intervention for treating alcohol dependence: relating elements of Medical Management to patient outcomes with implications for primary care.
Annals of family medicine 2008;6(5):435-40.
2008: Allen Zweben; Helen M Pettinati; Roger D Weiss; Marston Youngblood; Christine Cox; Margaret E Mattson; Prakash Gorroochurn; Domenic A Ciraulo
Relationship between medication adherence and treatment outcomes: the COMBINE study.
Alcoholism, clinical and experimental research 2008;32(9):1661-9.
2008: Falk W Lohoff; Paul J Bloch; Andrew E Weller; Aleksandra H Nall; Glenn A Doyle; Russell J Buono; Thomas N Ferraro; Kyle M Kampman; Helen M Pettinati; Charles Dackis; David W Oslin; Charles P O'Brien; Wade H Berrettini
Genetic variants in the cocaine- and amphetamine-regulated transcript gene (CARTPT) and cocaine dependence.
Neuroscience letters 2008;440(3):280-3.
2008: David W Oslin; Kevin G Lynch; Helen M Pettinati; Kyle M Kampman; Peter Gariti; Lois Gelfand; Thomas Ten Have; Shoshana Wortman; William Dundon; Charles Dackis; Joseph Robert Volpicelli; Charles P O'Brien
A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention.
Alcoholism, clinical and experimental research 2008;32(7):1299-308.
2008: W D Dundon; Helen M Pettinati; Kevin G Lynch; H Xie; K M Varillo; C Makadon; David W Oslin
The therapeutic alliance in medical-based interventions impacts outcome in treating alcohol dependence.
Drug and alcohol dependence 2008;95(3):230-6.
2008: Helen M Pettinati; Kyle M Kampman; Kevin G Lynch; Jesse Suh; Charles Dackis; David W Oslin; Charles P O'Brien
Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence.
Journal of substance abuse treatment 2008;34(4):378-90.
2008: Helen M Pettinati; Kyle M Kampman; Kevin G Lynch; Hu Xie; Charles Dackis; Amanda R Rabinowitz; Charles P O'Brien
A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence.
Addictive behaviors 2008;33(5):651-67.
2008: Domenic A Ciraulo; Qunming Dong; Bernard L Silverman; David Gastfriend; Helen M Pettinati
Early treatment response in alcohol dependence with extended-release naltrexone.
The Journal of clinical psychiatry 2008;69(2):190-5.
2008: Raymond F Anton; Gabor Oroszi; Stephanie O'Malley; David J Couper; Robert Swift; Helen M Pettinati; David Goldman
An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.
Archives of general psychiatry 2008;65(2):135-44.
2008: ahmadi ahmad; Kyle M Kampman; Charles Dackis; Thorne Sparkman; Helen M Pettinati
Cocaine withdrawal symptoms identify "Type B" cocaine-dependent patients.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2008;17(1):60-4.
2007: Kyle M Kampman; Helen M Pettinati; Kevin G Lynch; Tom Whittingham; Wayne Macfadden; Charles Dackis; Carlos Tirado; David W Oslin; Thorne Sparkman; Charles P O'Brien
A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism.
Journal of clinical psychopharmacology 2007;27(4):344-51.
2007: David Gastfriend; James C Garbutt; Helen M Pettinati; Robert Forman
Reduction in heavy drinking as a treatment outcome in alcohol dependence.
Journal of substance abuse treatment 2007;33(1):71-80.
2007: Helen M Pettinati
Letter to the editor in regard to Timko, DeBenedetti, Moos, and Moos (2006): "Predictors of 16-year mortality among individuals initiating help-seeking for an alcoholic use disorder".
Alcoholism, clinical and experimental research 2007;31(3):512.
2006: Helen M Pettinati; Charles P O'Brien; Amanda R Rabinowitz; Shoshana P Wortman; David W Oslin; Kyle M Kampman; Charles Dackis
The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
Journal of clinical psychopharmacology 2006;26(6):610-25.
2006: Kyle M Kampman; Charles Dackis; Kevin G Lynch; Helen M Pettinati; Carlos Tirado; Peter Gariti; Thorne Sparkman; Michal Atzram; Charles P O'Brien
A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
Drug and alcohol dependence 2006;85(2):129-37.
2006: Helen M Pettinati; Raymond F Anton; Mark L Willenbring
The COMBINE Study-: An Overview of the Largest Pharmacotherapy Study to Date for Treating Alcohol Dependence.
Psychiatry (Edgmont (Pa. : Township)) 2006;3(10):36-9.
2006: Helen M Pettinati; Amanda R Rabinowitz
Choosing the right medication for the treatment of alcoholism.
Current psychiatry reports 2006;8(5):383-8.
2006: Jesse Suh; Helen M Pettinati; Kyle M Kampman; Charles P O'Brien
The status of disulfiram: a half of a century later.
Journal of clinical psychopharmacology 2006;26(3):290-302.
2006: Raymond F Anton; Stephanie S O'Malley; Domenic A Ciraulo; Ron A Cisler; David J Couper; Dennis Donovan; David Gastfriend; James D Hosking; Bankole A Johnson; Joseph S Locastro; Richard Longabaugh; Barbara J Mason; Margaret E Mattson; William R Miller; Helen M Pettinati; Carrie L Randall; Robert Swift; Roger D Weiss; Lauren Williams; Allen Zweben
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2006;295(17):2003-17.
2006: Helen M Pettinati; Amanda R Rabinowitz
New pharmacotherapies for treating the neurobiology of alcohol and drug addiction.
Psychiatry (Edgmont (Pa. : Township)) 2006;3(5):14-6.
2006: Henry R Kranzler; Timothy Mueller; Jack Cornelius; Helen M Pettinati; Darlene Moak; Peter R Martin; Robert Anthenelli; Kirk J Brower; Stephanie O'Malley; Barbara J Mason; Deborah Hasin; Martin Keller
Sertraline treatment of co-occurring alcohol dependence and major depression.
Journal of clinical psychopharmacology 2006;26(1):13-20.
2005: Helen M Pettinati; Roger D Weiss; William Dundon; William R Miller; Dennis Donovan; Denise B Ernst; Bruce J Rounsaville
A structured approach to medical management: a psychosocial intervention to support pharmacotherapy in the treatment of alcohol dependence.
Journal of studies on alcohol. Supplement 2005;(15):170-8; discussion 168-9.
2005: Robert Swift; Helen M Pettinati
Choosing pharmacotherapies for the COMBINE Study--process and procedures: an investigational approach to combination pharmacotherapy for the treatment of alcohol dependence.
Journal of studies on alcohol. Supplement 2005;(15):141-7; discussion 140.
2005: James C Garbutt; Henry R Kranzler; Stephanie S O'Malley; David Gastfriend; Helen M Pettinati; Bernard L Silverman; John W Loewy; Elliot W Ehrich
Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2005;293(13):1617-25.
2005: James R McKay; Kevin G Lynch; Donald S Shepard; Helen M Pettinati
The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes.
Archives of general psychiatry 2005;62(2):199-207.
2005: James R McKay; Kevin G Lynch; Donald S Shepard; Jon Morgenstern; Robert Forman; Helen M Pettinati
Do patient characteristics and initial progress in treatment moderate the effectiveness of telephone-based continuing care for substance use disorders?
Addiction (Abingdon, England) 2005;100(2):216-26.
2005: Charles Dackis; Kyle M Kampman; Kevin G Lynch; Helen M Pettinati; Charles P O'Brien
A double-blind, placebo-controlled trial of modafinil for cocaine dependence.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(1):205-11.
2004: James R McKay; Kevin G Lynch; Donald S Shepard; Sara Ratichek; Rebecca Morrison; Janelle Koppenhaver; Helen M Pettinati
The effectiveness of telephone-based continuing care in the clinical management of alcohol and cocaine use disorders: 12-month outcomes.
Journal of consulting and clinical psychology 2004;72(6):967-79.
2004: Helen M Pettinati
Antidepressant treatment of co-occurring depression and alcohol dependence.
Biological psychiatry 2004;56(10):785-92.
2004: Kyle M Kampman; Helen M Pettinati; Kevin G Lynch; Charles Dackis; Thorne Sparkman; Catherine Weigley; Charles P O'Brien
A pilot trial of topiramate for the treatment of cocaine dependence.
Drug and alcohol dependence 2004;75(3):233-40.
2004: Raymond F Anton; Helen M Pettinati; Allen Zweben; Henry R Kranzler; Bankole Johnson; Michael J Bohn; Mary E McCaul; Robert Anthenelli; Ihsan Salloum; Gantt Galloway; James C Garbutt; Robert Swift; David Gastfriend; Antero Kallio; Sakari Karhuvaara
A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence.
Journal of clinical psychopharmacology 2004;24(4):421-8.
2004: William Dundon; Kevin G Lynch; Helen M Pettinati; Craig Lipkin
Treatment outcomes in type A and B alcohol dependence 6 months after serotonergic pharmacotherapy.
Alcoholism, clinical and experimental research 2004;28(7):1065-73.
2004: Jonathan Covault; Helen M Pettinati; Darlene Moak; Timothy Mueller; Henry R Kranzler
Association of a long-chain fatty acid-CoA ligase 4 gene polymorphism with depression and with enhanced niacin-induced dermal erythema.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2004;127B(1):42-7.
2004: Helen M Pettinati; William Dundon; Craig Lipkin
Gender differences in response to sertraline pharmacotherapy in Type A alcohol dependence.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2004;13(3):236-47.
2004: Kyle M Kampman; Helen M Pettinati; Joseph Robert Volpicelli; David M Oslin; Craig Lipkin; Thorne Sparkman; Charles P O'Brien
Cocaine dependence severity predicts outcome in outpatient detoxification from cocaine and alcohol.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2004;13(1):74-82.
2003: Maggie Nellissery; Richard Feinn; Jonathan Covault; Joel Gelernter; Raymond F Anton; Helen M Pettinati; Darlene Moak; Timothy Mueller; Henry R Kranzler
Alleles of a functional serotonin transporter promoter polymorphism are associated with major depression in alcoholics.
Alcoholism, clinical and experimental research 2003;27(9):1402-8.
2003: James R McKay; Kevin G Lynch; Helen M Pettinati; Donald S Shepard
An examination of potential sex and race effects in a study of continuing care for alcohol- and cocaine-dependent patients.
Alcoholism, clinical and experimental research 2003;27(8):1321-3.
2003: David W Oslin; Wade H Berrettini; Henry R Kranzler; Helen M Pettinati; Joel Gelernter; Joseph Robert Volpicelli; Charles P O'Brien
A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(8):1546-52.
2003: Helen M Pettinati; John Monterosso; Craig Lipkin; Joseph Robert Volpicelli
Patient attitudes toward treatment predict attendance in clinical pharmacotherapy trials of alcohol and drug treatment.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2003;12(4):324-35.
2003: Kyle M Kampman; Helen M Pettinati; Kevin G Lynch; Thorne Sparkman; Charles P O'Brien
A pilot trial of olanzapine for the treatment of cocaine dependence.
Drug and alcohol dependence 2003;70(3):265-73.
2003: Helen M Pettinati; Henry R Kranzler; Julie Madaras
The status of serotonin-selective pharmacotherapy in the treatment of alcohol dependence.
Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism 2003;16():247-62.
2002: David W Oslin; Helen M Pettinati; Joseph Robert Volpicelli
Alcoholism treatment adherence: older age predicts better adherence and drinking outcomes.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2002;10(6):740-7.
2002: Margaret Rukstalis; Kevin G Lynch; David W Oslin; Helen M Pettinati; Suzanne M Anderson; Joseph Robert Volpicelli; Raymond F Anton
Carbohydrate-deficient transferrin levels reflect heavy drinking in alcohol-dependent women seeking treatment.
Alcoholism, clinical and experimental research 2002;26(10):1539-44.
2002: James R McKay; Helen M Pettinati; Rebecca Morrison; Michael Feeley; Frank D Mulvaney; Robert Gallop
Relation of depression diagnoses to 2-year outcomes in cocaine-dependent patients in a randomized continuing care study.
Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors 2002;16(3):225-35.
2002: Barbara A Flannery; John P Allen; Helen M Pettinati; Damaris J Rohsenow; Ron A Cisler; Raye Z Litten
Using acquired knowledge and new technologies in alcoholism treatment trials.
Alcoholism, clinical and experimental research 2002;26(3):423-9.
2002: Kyle M Kampman; Joseph Robert Volpicelli; Frank D Mulvaney; Margaret Rukstalis; Arthur I Alterman; Helen M Pettinati; Robert M Weinrieb; Charles P O'Brien
Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence.
Addictive behaviors 2002;27(2):251-60.
2002: Kyle M Kampman; Helen M Pettinati; Joseph Robert Volpicelli; Gail Kaempf; Ellen Turk; Ambrose Insua; Craig Lipkin; Thorne Sparkman; Charles P O'Brien
Concurrent cocaine withdrawal alters alcohol withdrawal symptoms.
Journal of addictive diseases 2002;21(4):13-26.
2001: Helen M Pettinati; Joseph Robert Volpicelli; GJ Luck; Henry R Kranzler; Margaret Rukstalis; Avital Cnaan
Double-blind clinical trial of sertraline treatment for alcohol dependence.
Journal of clinical psychopharmacology 2001;21(2):143-53.
2001: John Monterosso; Barbara A Flannery; Helen M Pettinati; David W Oslin; Margaret Rukstalis; Charles P O'Brien; Joseph Robert Volpicelli
Predicting treatment response to naltrexone: the influence of craving and family history.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2001;10(3):258-68.
2000: Helen M Pettinati; Joseph Robert Volpicelli; Henry R Kranzler; GJ Luck; Margaret Rukstalis; Avital Cnaan
Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype.
Alcoholism, clinical and experimental research 2000;24(7):1041-9.
2000: Kyle M Kampman; Margaret Rukstalis; Helen M Pettinati; E Muller; T Acosta; Peter Gariti; Ronald N Ehrman; Charles P O'Brien
The combination of phentermine and fenfluramine reduced cocaine withdrawal symptoms in an open trial.
Journal of substance abuse treatment 2000;19(1):77-9.
2000: Helen M Pettinati; Margaret Rukstalis; GJ Luck; Joseph Robert Volpicelli; Charles P O'Brien
Gender and psychiatric comorbidity: impact on clinical presentation of alcohol dependence.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2000;9(3):242-52.
2000: Helen M Pettinati; Joseph Robert Volpicelli; JD Pierce; Charles P O'Brien
Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients.
Journal of addictive diseases 2000;19(1):71-83.
1999: Barbara A Flannery; Joseph Robert Volpicelli; Helen M Pettinati
Psychometric properties of the Penn Alcohol Craving Scale.
Alcoholism, clinical and experimental research 1999;23(8):1289-95.
1999: Kyle M Kampman; Margaret Rukstalis; Ronald N Ehrman; D E McGinnis; Peter Gariti; Joseph Robert Volpicelli; Helen M Pettinati; Charles P O'Brien
Open trials as a method of prioritizing medications for inclusion in controlled trials for cocaine dependence.
Addictive behaviors 1999;24(2):287-91.
1999: David W Oslin; Helen M Pettinati; Joseph Robert Volpicelli; A L Wolf; Kyle M Kampman; Charles P O'Brien
The effects of naltrexone on alcohol and cocaine use in dually addicted patients.
Journal of substance abuse treatment 1999;16(2):163-7.
1999: Helen M Pettinati; K Meyers; B D Evans; C R Ruetsch; F N Kaplan; J M Jensen; Trevor R Hadley
Inpatient alcohol treatment in a private healthcare setting: which patients benefit and at what cost?
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 1999;8(3):220-33.
1999: Helen M Pettinati; JD Pierce; P P Belden; K Meyers
The relationship of Axis II personality disorders to other known predictors of addiction treatment outcome.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 1999;8(2):136-47.
1998: David W Oslin; Helen M Pettinati; GJ Luck; A Semwanga; Avital Cnaan; Charles P O'Brien
Clinical correlations with carbohydrate-deficient transferrin levels in women with alcoholism.
Alcoholism, clinical and experimental research 1998;22(9):1981-5.
1998: Peter Gariti; Arthur I Alterman; Ronald N Ehrman; Helen M Pettinati
Reliability and validity of the aggregate method of determining number of cigarettes smoked per day.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 1998;7(4):283-7.
1997: Helen M Pettinati; JD Pierce; A L Wolf; Margaret Rukstalis; Charles P O'Brien
Gender differences in comorbidly depressed alcohol-dependent outpatients.
Alcoholism, clinical and experimental research 1997;21(9):1742-6.
1997: R S Saini; Helen M Pettinati; A E Semwanga; C P O'Brien
Carbohydrate-deficient transferrin: an investigative biochemical marker of heavy alcohol consumption.
Psychopharmacology bulletin 1997;33(1):171-5.
1996: B J Berg; Helen M Pettinati; Joseph Robert Volpicelli
A risk-benefit assessment of naltrexone in the treatment of alcohol dependence.
Drug safety : an international journal of medical toxicology and drug experience 1996;15(4):274-82.
1996: Helen M Pettinati
Use of serotonin selective pharmacotherapy in the treatment of alcohol dependence.
Alcoholism, clinical and experimental research 1996;20(7 Suppl):23A-29A.
1996: Helen M Pettinati; P P Belden; B D Evans; C R Ruetsch; Kathleen Meyers; J M Jensen
The natural history of outpatient alcohol and drug abuse treatment in a private healthcare setting.
Alcoholism, clinical and experimental research 1996;20(5):847-52.
1995: Kathleen Meyers; A Thomas McLellan; J L Jaeger; Helen M Pettinati
The development of the Comprehensive Addiction Severity Index for Adolescents (CASI-A). An interview for assessing multiple problems of adolescents.
Journal of substance abuse treatment 1995;12(3):181-93.
1994: Helen M Pettinati; T A Tamburello; C R Ruetsch; F N Kaplan
Patient attitudes toward electroconvulsive therapy.
Psychopharmacology bulletin 1994;30(3):471-5.
1993: Helen M Pettinati; Kathleen Meyers; J M Jensen; F Kaplan; B D Evans
Inpatient vs outpatient treatment for substance dependence revisited.
The Psychiatric quarterly 1993;64(2):173-82.
1991: S M Stephens; R M Greenberg; Helen M Pettinati
Choosing an electroconvulsive therapy device.
The Psychiatric clinics of North America 1991;14(4):989-1006.
1990: Helen M Pettinati; S M Stephens; K M Willis; S E Robin
Evidence for less improvement in depression in patients taking benzodiazepines during unilateral ECT.
The American journal of psychiatry 1990;147(8):1029-35.
1990: J A Mattes; Helen M Pettinati; S Stephens; S E Robin; K W Willis
A placebo-controlled evaluation of vasopressin for ECT-induced memory impairment.
Biological psychiatry 1990;27(3):289-303.
1990: Helen M Pettinati; L G Kogan; F J Evans; J H Wade; R L Horne; J M Staats
Hypnotizability of psychiatric inpatients according to two different scales.
The American journal of psychiatry 1990;147(1):69-75.
1990: Helen M Pettinati; R A Cabezas; J Jensen; B D Evans; K Meyers
Incidence of personality disorders in cocaine vs. alcohol-dependent females.
NIDA research monograph 1990;105():369-70.
1990: K Meyers; J L Jaeger; V N Valliere; J M Jensen; Helen M Pettinati; B D Evans; P Sargiotto
HIV-risk behaviors among a middle class population: a preliminary investigation among adolescent vs. adult substance users.
NIDA research monograph 1990;105():351-2.
1990: J M Jensen; Helen M Pettinati; B D Evans; K Meyers; V N Valliere
Impulsivity and substance abusers: changes with treatment and recovery.
NIDA research monograph 1990;105():287-8.
1989: B H Dritschel; Helen M Pettinati
The role of female occupation in severity of alcohol-related problems.
The American journal of drug and alcohol abuse 1989;15(1):61-72.
1989: J A Mattes; Helen M Pettinati; S M Nilsen; S E Robin; K W Willis
Vasopressin for ECT-induced memory impairment: a placebo-controlled comparison.
Psychopharmacology bulletin 1989;25(1):80-4.
1989: Helen M Pettinati; B Evans; C Joseph; J Jensen; K Meyers
Differential anxiety symptoms in cocaine vs. alcoholic patients.
NIDA research monograph 1989;95():471-2.
1988: A Kight-Law; A A Sugerman; Helen M Pettinati
An application of an MMPI classification system for predicting outcome in a small clinical sample of alcoholics.
The American journal of drug and alcohol abuse 1988;14(3):325-34.
1987: Helen M Pettinati; V Franks; J H Wade; L G Kogan
Distinguishing the role of eating disturbance from depression in the sex role self-perceptions of anorexic and bulimic inpatients.
Journal of abnormal psychology 1987;96(3):280-2.
1986: Helen M Pettinati; J H Wade
Hypnosis in the treatment of anorexic and bulimic patients.
Seminars in adolescent medicine 1986;2(1):75-9.
1985: R L Horne; Helen M Pettinati; A A Sugerman; E Varga
Comparing bilateral to unilateral electroconvulsive therapy in a randomized study with EEG monitoring.
Archives of general psychiatry 1985;42(11):1087-92.
1985: Helen M Pettinati; R L Horne; J M Staats
Hypnotizability in patients with anorexia nervosa and bulimia.
Archives of general psychiatry 1985;42(10):1014-6.
1984: R L Horne; Helen M Pettinati; M Menken; A A Sugerman; E Varga; G F Wilson
Dexamethasone in electroconvulsive therapy: efficacy for depression and post-ECT amnesia.
Biological psychiatry 1984;19(1):13-27.
1982: Helen M Pettinati; A A Sugerman; N DiDonato; H S Maurer
The natural history of alcoholism over four years after treatment.
Journal of studies on alcohol 1982;43(3):201-15.
1982: Helen M Pettinati; A A Sugerman; H S Maurer
Four year MMPI changes in abstinent and drinking alcoholics.
Alcoholism, clinical and experimental research 1982;6(4):487-94.
1981: Helen M Pettinati; F J Evans; E C Orne; M T Orne
Restricted use of success cues in retrieval during posthypnotic amnesia.
Journal of abnormal psychology 1981;90(4):345-53.